These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28839265)

  • 41. Catechins and the treatment of breast cancer: possible utility and mechanistic targets.
    Rosengren RJ
    IDrugs; 2003 Nov; 6(11):1073-8. PubMed ID: 14600840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance.
    Jin K; Park S; Teo WW; Korangath P; Cho SS; Yoshida T; Győrffy B; Goswami CP; Nakshatri H; Cruz LA; Zhou W; Ji H; Su Y; Ekram M; Wu Z; Zhu T; Polyak K; Sukumar S
    Cancer Discov; 2015 Sep; 5(9):944-59. PubMed ID: 26180042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic strategies to induce ERα in luminal breast cancer to enhance tamoxifen efficacy.
    Esakov EL; Hale J; Richards EG; Torre-Healy L; Gullapalli K; Trivedi D; Chumakova A; Wessely O; Jensen J; Lathia J; Reizes O
    Endocr Relat Cancer; 2019 Aug; 26(8):689-698. PubMed ID: 31167163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combinatorial epigenetic mechanisms of sulforaphane, genistein and sodium butyrate in breast cancer inhibition.
    Sharma M; Tollefsbol TO
    Exp Cell Res; 2022 Jul; 416(1):113160. PubMed ID: 35447103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tamoxifen synergizes with 4-(E)-{(4-hydroxyphenylimino)-methylbenzene, 1,2-diol} and 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, novel azaresveratrol analogs, in inhibiting the proliferation of breast cancer cells.
    Ronghe A; Chatterjee A; Bhat NK; Padhye S; Bhat HK
    Oncotarget; 2016 Aug; 7(32):51747-51762. PubMed ID: 27351134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression.
    Zhang B; Zhang X; Tang B; Zheng P; Zhang Y
    Breast Cancer Res Treat; 2012 Nov; 136(2):399-406. PubMed ID: 23053650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoantibodies Specific to ERα are Involved in Tamoxifen Resistance in Hormone Receptor Positive Breast Cancer.
    Maselli A; Parlato S; Puglisi R; Raggi C; Spada M; Macchia D; Pontecorvi G; Iessi E; Pagano MT; Cirulli F; Gabriele L; Carè A; Vici P; Pizzuti L; Barba M; Matarrese P; Pierdominici M; Ortona E
    Cells; 2019 Jul; 8(7):. PubMed ID: 31331091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Promoting E2F1-mediated apoptosis in oestrogen receptor-α-negative breast cancer cells.
    Montenegro MF; Collado-González Mdel M; Fernández-Pérez MP; Hammouda MB; Tolordava L; Gamkrelidze M; Rodríguez-López JN
    BMC Cancer; 2014 Jul; 14():539. PubMed ID: 25064027
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways.
    Chen J; Power KA; Mann J; Cheng A; Thompson LU
    Nutr Cancer; 2007; 58(2):162-70. PubMed ID: 17640162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator.
    McDougal A; Wormke M; Calvin J; Safe S
    Cancer Res; 2001 May; 61(10):3902-7. PubMed ID: 11358803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells.
    Hsieh TC; Wu JM
    Int J Oncol; 2008 Oct; 33(4):851-9. PubMed ID: 18813800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation.
    Paul B; Li Y; Tollefsbol TO
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
    Keeton EK; Brown M
    Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance.
    Bekele RT; Venkatraman G; Liu RZ; Tang X; Mi S; Benesch MG; Mackey JR; Godbout R; Curtis JM; McMullen TP; Brindley DN
    Sci Rep; 2016 Feb; 6():21164. PubMed ID: 26883574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oestrogen receptor-regulated glutathione S-transferase mu 3 expression attenuates hydrogen peroxide-induced cytotoxicity, which confers tamoxifen resistance on breast cancer cells.
    Lin JH; Tu SH; Chen LC; Huang CC; Chang HL; Cheng TC; Chang HW; Wu CH; Wu HC; Ho YS
    Breast Cancer Res Treat; 2018 Nov; 172(1):45-59. PubMed ID: 30054830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sulforaphane and Epigallocatechin Gallate Restore Estrogen Receptor Expression by Modulating Epigenetic Events in the Breast Cancer Cell Line MDA-MB-231: A Systematic Review and Meta-Analysis.
    Gianfredi V; Vannini S; Moretti M; Villarini M; Bragazzi NL; Izzotti A; Nucci D
    J Nutrigenet Nutrigenomics; 2017; 10(3-4):126-135. PubMed ID: 29040973
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Temporal Efficacy of a Sulforaphane-Based Broccoli Sprout Diet in Prevention of Breast Cancer through Modulation of Epigenetic Mechanisms.
    Li Y; Buckhaults P; Li S; Tollefsbol T
    Cancer Prev Res (Phila); 2018 Aug; 11(8):451-464. PubMed ID: 29764806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells.
    Royston KJ; Udayakumar N; Lewis K; Tollefsbol TO
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic impact of dietary isothiocyanates in cancer chemoprevention.
    Gerhauser C
    Curr Opin Clin Nutr Metab Care; 2013 Jul; 16(4):405-10. PubMed ID: 23657153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.